Identification of potential biomarkers of tryptophan metabolism in Kawasaki disease and exploration of potential mechanisms. [PDF]
Transl PediatrYuan Y +5 more
europepmc +1 more source
Safety and efficacy of fixed-dose combination of dapagliflozin and saxagliptin in patients with type 2 diabetes mellitus - a phase 4 study in India. [PDF]
Front Endocrinol (Lausanne)Wangnoo SK +9 more
europepmc +1 more source
The Dipeptidyl Peptidase-4 Inhibitor Saxagliptin as a Candidate Treatment for Disorders of Consciousness: A Deep Learning and Retrospective Clinical Analysis. [PDF]
Neurocrit CareToker D +4 more
europepmc +1 more source
Costs and cost-effectiveness of type 2 diabetes management in Sub-Saharan Africa: a systematic review. [PDF]
Health Econ RevHellebo A, Kengne AP, Alaba OA.
europepmc +1 more source
Comment on "SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis" critical considerations on biomarker validation and Supraphysiological drug concentrations. [PDF]
J Transl MedChen J, Yan L.
europepmc +1 more source
Dietary Modulation of CYP3A4 and Its Impact on Statins and Antidiabetic Drugs: A Narrative Review. [PDF]
Pharmaceuticals (Basel)Hernández-Lorca M +6 more
europepmc +1 more source
Methods for kinetic evaluation of reversible covalent inhibitors from time-dependent IC<sub>50</sub> data. [PDF]
RSC Med ChemMader LK, Keillor JW.
europepmc +1 more source
Acute Pancreatitis Associated With Anaphylactic Shock: A Case Report and Literature Review. [PDF]
CureusLeclercq G, Guerisse F.
europepmc +1 more source